SCHEMBL20644386

SCHEMBL20644386

CC[C@@H]([C@H](C)OC(=O)CN(C)C)n1ncn(C)c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20644580 0.80 LMNA (0.33) —
SCHEMBL20644408 0.78 MAPT (0.31) —
SCHEMBL25160180 0.78 TDP1 (0.33) —
SCHEMBL20644380 0.77 PRMT5 (0.30) —
SCHEMBL20644697 0.74 KDM4E (0.30) —
SCHEMBL18258252 0.74 MAPT (0.35) —
SCHEMBL20644426 0.66 MAPT (0.33) —
SCHEMBL10299282 0.63 MMP1 (0.32) —
SCHEMBL19821996 0.62 CTSL (0.37) —
SCHEMBL11377573 0.59 SMN1; SMN2 (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10464922-B2 Metalloenzyme inhibitor compounds NQP 1598, LTD. (US) 2019-11-05 — — US disclosed
US-20190016700-A1 METALLOENZYME INHIBITOR COMPOUNDS NQP 1598, LTD. (KY) 2019-01-17 — — US disclosed
Send feedback